BIOMAT Database Logo BIOMAT Database Logo

[Characteristics of immunological phenomena in hepatitis B virus (HBV) infection]. 1987

J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński

UI MeSH Term Description Entries
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic

Related Publications

J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
[Hepatitis B virus (HBV) infection and hepatocarcinogenesis].
June 2010, Orvosi hetilap,
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
Chronic hepatitis B virus (HBV) infection in pregnancy.
September 2008, Hepatology international,
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.
January 2006, International journal of medical sciences,
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
Immunological aspects of hepatitis B virus infection.
January 1975, The American journal of the medical sciences,
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
Hepatitis B virus (HBV) and dual HBV-hepatitis delta virus (HDV) infection in apparently healthy persons.
January 1998, Romanian journal of virology,
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
Erythema nodosum and hepatitis B virus (HBV) infection.
October 1983, Journal of the American Academy of Dermatology,
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
Hepatitis B virus infection with negative HBV-serology.
September 1982, Lancet (London, England),
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
[Glomerulonephropathy associated with hepatitis B virus (HBV) infection].
September 1990, Zhonghua nei ke za zhi,
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
Updates on Hepatitis B Virus (HBV) Infection 2.0.
November 2023, Microorganisms,
J Stachowski, and J Michałkiewicz, and J Wiernicka, and J Maciejewski, and K Madaliński
Innate immune responses in hepatitis B virus (HBV) infection.
February 2014, Virology journal,
Copied contents to your clipboard!